Deliver a New Level of Care
Make more informed clinical decisions — and support population health — with one connected chronic care platform for multiple cardiometabolic conditions and comorbidities.
Discover between-visit chronic care.
- Type 1 & Type 2 Diabetes*
- Hypertension
- Heart Failure
- Weight & Obesity Management
- Prediabetes
- Heart Failure
- Behavioral Health
- Prediabetes
- Type 1 and Type 2 Diabetes
- Hypertension
One connected chronic care hub that integrates seamlessly into existing clinical systems and workflows
Welldoc is differentiated by clinical rigor and industry recognition
11
510(k) FDA-Clearances*
80+
Clinical Publications
45
Patents
*Welldoc® Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.com. The other Welldoc App products are non- FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.
Coordinated, data-driven chronic care — between office visits
- The Welldoc Application
- Ongoing Engagement
- Population Management
The Welldoc Platform supports population health by providing care teams with enhanced health data and analytics on individuals and groups — helping organizations reduce redundancies, close care gaps, and more effectively coordinate data and care.
Welldoc seamlessly integrates real-time, actionable, patient-generated data (e.g., weight, blood pressure and blood glucose patterns) into existing clinical workflows, enabling your care teams to draw connections and deep learning with pattern-based insights and reporting.
The Welldoc Platform supports population health by providing care teams with enhanced health data and analytics on individuals and groups — helping organizations reduce redundancies, close care gaps, and more effectively coordinate data and care.
- The Welldoc Application
- Ongoing Engagement
- Population Management
Chronic conditions account for up to 75% of all healthcare costs.1
Consistent engagement supports better self-management and health outcomes
Cost Optimization
complications
*Welldoc® Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.com. The other Welldoc App products are non- FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.
References:
1 Norbeck TB. Drivers of Health Care Costs. Missouri Medicine. 2013;110(2):113-118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179664/
2 Snow, K. Iyer, A. Shearer, D. Peeples, M. Interactive Digital Health: Engaging Health Behaviors & Clinical Outcomes. Poster presented at: ADCES 2020 Virtual Conference, August 2020.
3 Tang PY, Duni J, Peeples MM, et al. Complementarity of digital health and peer support: “This Is What’s Coming.” Front Clin Diabetes Health. 2021;2. doi:10.3389/fcdhc.2021.646963
4 Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention for Glycemic Control. Journal of Diabetes Science and Technology. 2014;8(2):362-370. doi:10.1177/1932296813514503
5 Kumbara A, Iyer A, Shomali M. Blood pressure improvement in people using a digital health solution for comprehensive diabetes self-management. Poster presented at: 16th Annual Cardiometabolic Health Congress; October 14-17, 2021; National Harbor, MD.
6 IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc sponsored report 2018. Published August 2018.
